268 related articles for article (PubMed ID: 19594276)
1. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review.
Hamilton JG; Lobel M; Moyer A
Health Psychol; 2009 Jul; 28(4):510-8. PubMed ID: 19594276
[TBL] [Abstract][Full Text] [Related]
2. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
3. Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.
Reichelt JG; Møller P; Heimdal K; Dahl AA
Fam Cancer; 2008; 7(3):245-54. PubMed ID: 18219587
[TBL] [Abstract][Full Text] [Related]
4. Psychological impact of receiving a BRCA1/BRCA2 test result.
Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
[TBL] [Abstract][Full Text] [Related]
5. Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.
Claes E; Evers-Kiebooms G; Denayer L; Decruyenaere M; Boogaerts A; Philippe K; Legius E
J Genet Couns; 2005 Oct; 14(5):349-63. PubMed ID: 16195942
[TBL] [Abstract][Full Text] [Related]
6. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
7. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
[TBL] [Abstract][Full Text] [Related]
8. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
Lodder L; Frets PG; Trijsburg RW; Klijn JG; Seynaeve C; Tilanus MM; Bartels CC; Meijers-Heijboer EJ; Verhoog LC; Niermeijer MF
Am J Med Genet A; 2003 Jun; 119A(3):266-72. PubMed ID: 12784290
[TBL] [Abstract][Full Text] [Related]
9. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
[TBL] [Abstract][Full Text] [Related]
10. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE
J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679
[TBL] [Abstract][Full Text] [Related]
11. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
[TBL] [Abstract][Full Text] [Related]
12. Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.
McKinnon W; Naud S; Ashikaga T; Colletti R; Wood M
J Genet Couns; 2007 Aug; 16(4):433-56. PubMed ID: 17594133
[TBL] [Abstract][Full Text] [Related]
13. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L
Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021
[TBL] [Abstract][Full Text] [Related]
14. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
O'Neill SC; Rini C; Goldsmith RE; Valdimarsdottir H; Cohen LH; Schwartz MD
Psychooncology; 2009 Oct; 18(10):1088-96. PubMed ID: 19214961
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
16. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
Tercyak KP; Peshkin BN; Streisand R; Lerman C
Psychooncology; 2001; 10(4):336-46. PubMed ID: 11462232
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.
Rini C; O'Neill SC; Valdimarsdottir H; Goldsmith RE; Jandorf L; Brown K; DeMarco TA; Peshkin BN; Schwartz MD
Health Psychol; 2009 Sep; 28(5):569-578. PubMed ID: 19751083
[TBL] [Abstract][Full Text] [Related]
18. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.
Sussner KM; Thompson HS; Jandorf L; Edwards TA; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
Psychooncology; 2009 Sep; 18(9):945-55. PubMed ID: 19090507
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370
[TBL] [Abstract][Full Text] [Related]
20. BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.
McInerney-Leo A; Hadley D; Kase RG; Giambarresi TR; Struewing JP; Biesecker BB
Am J Med Genet A; 2006 Oct; 140(20):2198-206. PubMed ID: 16969872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
